Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at ZAR 340.3B, ahead of Merck & Co (ZAR 251.5B) and Novartis (ZAR 197.4B). Figures as of 18 Nov 2026, 21:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonZAR 340.3B
- Median
- ZAR 9.9B
- Combined market value
- ZAR 87.35T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | ZAR 340.3B | ZAR 11.34T | ZAR 4,708.66 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | ZAR 251.5B | ZAR 5.86T | ZAR 2,379.02 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | ZAR 197.4B | ZAR 5.06T | ZAR 2,679.98 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | ZAR 176.3B | ZAR 2.1T | ZAR 1,028.41 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | ZAR 147.1B | ZAR 3.12T | ZAR 1,804.04 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | ZAR 146.7B | ZAR 1.95T | ZAR 813.61 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | ZAR 125.5B | ZAR 21.27T | ZAR 23,875.67 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | ZAR 98.6B | ZAR 4.79T | ZAR 3,086.61 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | ZAR 90.3B | ZAR 8.73T | ZAR 4,938.48 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 87.8B | ZAR 2.35T | ZAR 9,262.77 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | ZAR 78.5B | ZAR 796B | ZAR 6,968.88 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | ZAR 77.9B | ZAR 1.68T | ZAR 838.82 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | ZAR 67.8B | ZAR 3T | ZAR 680.83 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | ZAR 64.3B | ZAR 1.17T | ZAR 367.26 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 61.4B | ZAR 850.8B | ZAR 729.18 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 53.8B | ZAR 1.69T | ZAR 16,326.28 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | ZAR 39.9B | ZAR 600.3B | ZAR 1,477.52 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | ZAR 29.6B | ZAR 542.7B | ZAR 880.09 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 28.6B | ZAR 345.5B | ZAR 2,579.66 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | ZAR 26.9B | ZAR 424.6B | ZAR 9,968.81 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | ZAR 24.5B | ZAR 484.5B | ZAR 668.74 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 24B | ZAR 274.6B | ZAR 4,278.20 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | ZAR 22.8B | ZAR 401.5B | ZAR 350.17 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 22.6B | ZAR 205.5B | ZAR 1,060.70 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | ZAR 19.7B | ZAR 2.76T | ZAR 484.51 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | ZAR 17B | ZAR 86.9B | ZAR 1,039.98 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | ZAR 15.8B | ZAR 99.5B | ZAR 146.25 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | ZAR 15.6B | ZAR 54.4B | ZAR 280.59 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | ZAR 11.8B | ZAR 306.2B | ZAR 4,667.73 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | ZAR 10.7B | ZAR 681.8B | ZAR 1,185.71 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | ZAR 9.9B | ZAR 126.7B | ZAR 1,447.48 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | ZAR 9.8B | ZAR 262.4B | ZAR 1,346.98 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | ZAR 9.4B | ZAR 230.4B | ZAR 461.02 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | ZAR 8.8B | ZAR 453.8B | ZAR 2,068.56 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | ZAR 6.7B | ZAR 135.9B | ZAR 808.95 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | ZAR 6.4B | ZAR 78.8B | ZAR 472.94 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | ZAR 6.2B | ZAR 147.3B | ZAR 5,269.65 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | ZAR 6.1B | ZAR 109.6B | ZAR 2,697.59 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | ZAR 5.6B | ZAR 121.7B | ZAR 2,313.75 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | ZAR 5.4B | ZAR 83.6B | ZAR 480.19 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 5.1B | ZAR 104.3B | ZAR 1,597.01 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 4.9B | ZAR 131.6B | ZAR 377.80 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | ZAR 4.5B | ZAR 68.8B | ZAR 502.81 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 3.9B | ZAR 105.2B | ZAR 744.37 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | ZAR 3.9B | ZAR 145B | ZAR 181.30 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 3.4B | ZAR 159.7B | ZAR 6,873.57 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | ZAR 3B | ZAR 103.2B | ZAR 5,157.77 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 2.9B | ZAR 129B | ZAR 1,641.21 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 2.8B | ZAR 215.6B | ZAR 258.66 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | ZAR 2.2B | ZAR 143.3B | ZAR 2,195.65 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | ZAR 2.1B | ZAR 123.4B | ZAR 886.13 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | ZAR 2.1B | ZAR 128.1B | ZAR 1,170.52 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | ZAR 1.6B | ZAR 83.3B | ZAR 867.48 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | ZAR 1.5B | ZAR 166.4B | ZAR 1,751.89 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | ZAR 1.4B | ZAR 172.6B | ZAR 1,141.68 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | ZAR 1.3B | ZAR 83.4B | ZAR 237.59 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | ZAR 1.1B | ZAR 78.2B | ZAR 714.33 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 937.6M | ZAR 142.5B | ZAR 2,055.44 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | ZAR 882.1M | ZAR 81.7B | ZAR 1,450.07 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | ZAR 810.4M | ZAR 112.1B | ZAR 1,653.12 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | ZAR 375.8M | ZAR 91B | ZAR 2,155.93 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2668 ZAR).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (ZAR 340.3B), Merck & Co (ZAR 251.5B) and Novartis (ZAR 197.4B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 18 Nov 2026, 21:48 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of ZAR 87.35T as of 18 Nov 2026, 21:48 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.